Toronto, ON, June 11, 2019 (GLOBE NEWSWIRE) --
It is estimated that 5% of the global population is affected by Major Depressive Disorder (MDD) at any given time. While there are many antidepressant drugs on the market, most of these drugs need weeks to take effect, if at all. This exciting new project hopes to develop a novel rapid-acting antidepressant that has the potential to provide patient relief much faster than conventional treatments.
The project builds on years of research led by Dr. ...
Read more